Feng Hu
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms 5
-
- Immune cells in cancer 4
- interferon and immune responses 2
-
- Glioma Diagnosis and Treatment 4
- Genomics and Rare Diseases 1
-
- Cancer-related molecular mechanisms research 2
-
- Spine and Intervertebral Disc Pathology 2
-
- COVID-19 and healthcare impacts 1
- Co-authors
- Helmut KettenmannMan LiJixiang ChenLei ZhaoYing BiAleksandra Ellert‐MiklaszewskaPiotr PrzanowskiArkadiusz Piotrowski
- Journals
- Journal of Neuropathology & Experimental Neurology (1 paper)Cancers (1 paper)Journal of Molecular Medicine (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Feng Hu
17 papers receiving 427 citations
Peers
Comparison fields: 5 of 69
- Neurology 104
- Immunology 187
- Biological Psychiatry 15
- Genetics 45
- Developmental Neuroscience 15
Countries citing papers authored by Feng Hu
This map shows the geographic impact of Feng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Hu more than expected).
Fields of papers citing papers by Feng Hu
This network shows the impact of papers produced by Feng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Hu. The network helps show where Feng Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Feng Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 8 | |
| 8 | 2022 | 16 | |
| 9 | 2022 | 9 | |
| 10 | 2021 | 1 | |
| 11 | 2020 | 14 | |
| 12 | MEK inhibitor trametinib attenuates neuroinflammation and cognitive deficits following traumatic brain injury in mice. | 2020 | 16 |
| 13 | 2019 | 24 | |
| 14 | 2019 | 7 | |
| 15 | 2019 | 109 | |
| 16 | 2018 | 1 | |
| 17 | 2016 | 61 | |
| 18 | 2014 | 1 | |
| 19 | 2013 | 159 | |
| 20 | 2010 | 2 |
About Feng Hu
Feng Hu is a scholar working on Neurology, Genetics and Immunology, having authored 20 papers that have together received 432 indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Glioma Diagnosis and Treatment (4 papers), Immune cells in cancer (4 papers), interferon and immune responses (2 papers), Cancer-related molecular mechanisms research (2 papers), Spine and Intervertebral Disc Pathology (2 papers), COVID-19 and healthcare impacts (1 paper) and Genomics and Rare Diseases (1 paper). The work is most often cited by research in Neurology (104 citations), Immunology (187 citations) and Biological Psychiatry (15 citations). Feng Hu has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Helmut Kettenmann, Man Li, Jixiang Chen, Lei Zhao, Ying Bi, Aleksandra Ellert‐Miklaszewska, Piotr Przanowski, Arkadiusz Piotrowski, Jakub Mieczkowski and Jan Komorowski. Their work appears in journals such as Journal of Neuropathology & Experimental Neurology, Cancers and Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.